Thousands of young women in South Asia who have been diagnosed with gynaecologic cancer face more than just the disease itself. What follows is a rapid, violent, and medically caused menopause—flashes, sweats, and excruciating symptoms—which is frequently exacerbated by doctors' dread of administering the most effective treatment: hormone therapy. 

A recent study published in Menopause, The Menopause Society's publication, identifies a major gap in medical practice. Despite overwhelming proof of its safety for patients with low-grade endometrial or ovarian cancer, many gynaecologists are still hesitant to prescribe oestrogen therapy due to antiquated concerns about cancer recurrence. 

This study, albeit undertaken in the United States, has serious consequences for the Global South. For decades, genetic and clinical research has primarily concentrated on people of European heritage, leaving a hazardous information gap. This "multi-ancestry" approach to understanding treatment safety is not only advantageous; it is critical for places like South Asia, where healthcare facilities are already overburdened and patients cannot afford to get therapy based on insufficient data. 

The study of nearly 300 experts discovered that, while more than 63% would prescribe oestrogen for endometrial cancer patients, comfort levels differed greatly depending on a doctor's expertise and speciality. The most common reason for refusal was the idea that "the risks outweighed the benefits"—a myth that the study seeks to debunk. 

"Treatment for gynaecologic cancers often accelerates the onset of menopause and contributes to more severe symptoms in this population," says Dr Monica Christmas, The Menopause Society's associate medical director. "Hormone therapy is the best treatment... Recognising when it is safe to use will improve your general well-being and health. 

The consequences are immense. In areas where women are frequently primary carers, improving their quality of life with safe, effective treatment has a knock-on effect on family stability and economic well-being. It also reduces the burden on public health systems by removing the need to treat complex menopausal symptoms with less effective options. 

The findings draw attention to the urgent requirement for focused clinician education in medical communities around the world. For a young lady in Delhi, Dhaka, or Colombo who has survived cancer, it offers optimism that her future will be defined by health and fulfilment rather than misery.